SALT LAKE CITY, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride ceramics as a platform for biomedical applications, today announced financial results for the third quarter ended September 30, 2015.
Recent Company Highlights
- Cash and cash equivalents totaled $11.3 million, and net cash used in operating activities during the quarter decreased by $1.3 million, or 43%, from the prior year period
- Reduced debt principal balance by $3.5 million, or 14%, and eliminated conversion feature of the convertible note
Help employers find you! Check out all the jobs and post your resume.
